Omega 3 Fatty Acid Treatment for Pediatric Musculoskeletal Health

NCT03127345 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Lack of funding

Conditions

Esophageal Atresia

Interventions

DRUG: Omegaven
DRUG: Intralipid

Sponsor

Boston Children's Hospital